| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | OSTIIO LLC | 3401 GRAYS FERRY AVE | PHILADELPHIA | PA | 19146-2701 | PHILADELPHIA | USA | R44DE031195 | A Smart, Fully Subcutaneous Distraction System to Improve Outcomes in Patients with Congenital or Acquired Craniofacial Differences | 000 | 3 | NIH | 8/13/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $849,999 ) |
| | 2024 | 2024 | OSTIIO LLC | 3401 GRAYS FERRY AVE | PHILADELPHIA | PA | 19146-2701 | PHILADELPHIA | USA | R44DE031195 | A Smart, Fully Subcutaneous Distraction System to Improve Outcomes in Patients with Congenital or Acquired Craniofacial Differences | 000 | 3 | NIH | 7/25/2024 | $849,999 |
|
| Issue Date FY: 2023 ( Subtotal = $892,501 ) |
| | 2023 | 2023 | OSTIIO LLC | 3401 GRAYS FERRY AVE | PHILADELPHIA | PA | 19146-2701 | PHILADELPHIA | USA | R44DE031195 | A Smart, Fully Subcutaneous Distraction System to Improve Outcomes in Patients with Congenital or Acquired Craniofacial Differences | 000 | 2 | NIH | 9/14/2023 | $892,501 |
| | 2023 | 2022 | OSTIIO LLC | 3401 GRAYS FERRY AVE | PHILADELPHIA | PA | 19146-2701 | PHILADELPHIA | USA | R43DE031195 | A Smart, Fully Subcutaneous Distraction System to Improve Outcomes in Patients with Congenital or Acquired Craniofacial Differences | 000 | 1 | NIH | 6/6/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $300,000 ) |
| | 2022 | 2022 | OSTIIO LLC | 3401 GRAYS FERRY AVE BLDG 176-1011 | PHILADELPHIA | PA | 19146-2701 | PHILADELPHIA | USA | R43DE031195 | A Smart, Fully Subcutaneous Distraction System to Improve Outcomes in Patients with Congenital or Acquired Craniofacial Differences | 000 | 1 | NIH | 12/1/2021 | $300,000 |
|
|
